← Eichor
Study identifier: NCT06991062 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHASE

Condition: Smoking  ·  Sponsor: M.D. Anderson Cancer Center

PhaseNA
Planned participants100
Who can joinAll sexes, 21 Years to 60 Years
Healthy volunteersNo

About this study

The goal of this clinical research study is to learn more about whether individual differences in brain responses to emotional triggers impact rTMS (repetitive transcranial magnetic stimulation) responses in people who smoke.

This description comes directly from the study's public registry record.

Talk to the study team

Francesco Versace, PHD  ·  (713) 745-7933  ·  fversace@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (1)

The University of Texas M. D. Anderson Cancer CenterHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06991062